Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 679-526-3 | CAS number: 337906-36-2
Endpoint summary
Administrative data
Description of key information
The acute oral toxicity of MBB or MBB SULFATE 1:1 was determined based on the maximum tolerated dose (MTD) after oral application in in vivo genotoxicity studies in rats carried out with the sulfate salt. The determination of the MTD (with respect to the number of animals used and dose selection) was in line with the OECD guideline 423 for the determination of acute oral toxicity. The approach to determine the acute oral toxicity by using MTD data from in vivo genotoxicity studies is accepted by the German and EU regulatory agencies and is based on the current state-of-the-art science. The calculated oral LD50 values (LD50, calc, oral) for the sulfate salt and free base of 2- METHOXY-METHYL-P-PHENYLENEDIAMINE were determined to be 150 mg/kg bw and 91.5 mg/kg bw, respectively. The LD50, calc, oral for the sulfate salt (150 mg/kg bw) was used for the route extrapolation calculations, since the in vivo toxicity and kinetics assays used in the calculations were also carried out with the sulfate salt.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 91.5 mg/kg bw
- Quality of whole database:
- free base
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 1 080 mg/m³ air
- Quality of whole database:
- free base
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 366 mg/kg bw
- Quality of whole database:
- free base
Additional information
The acute inhalational and dermal toxicity of 2-METHOXY-METHYL-P- HENYLENEDIAMINE was determined using kinetics-based data derived from an ADME study in rats with the sulfate salt.
The calculated LD50 for the oral toxicity was 150 mg/kg b.w. and 91.5 mg/kg bw for the for the sulfate salt and free base, respectively.
The calculated LC50 for the inhalation toxicity (LC50 calc inhal.) was 1.77 mg/L and 1.08 mg/L for the sulfate salt and free base, respectively. When these concentrations are combined with the results of in vitro eye irritation studies, it can be concluded that 2-METHOXY-METHYL-P-PHENYLENEDIAMINE would not have a local effect in the lungs.
The calculated LD50 value for the dermal toxicity was 600 mg/kg bw and 366 mg/kg bw for the for the sulfate salt and free base, respectively.
Justification for classification or non-classification
The LD50 values determined or calculated served as criteria for applying CLP classification.
The substance2-METHOXY-METHYL-P-PHENYLENEDIAMINE was considered as acute tox 3 : toxic if swallowed, in contact with skin (H301,H311) and acute tox 4 : harmful if inhaled (H332)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
